Jeff Geschwind

Jeff Geschwind is an accomplished medical professional with extensive experience in oncology and radiology. Currently serving as the Director of Oncology at USA Vein Clinics and USA Fibroid Centers since March 2019, Jeff also holds consultancy roles at Philips and Syntactx, where Jeff plays a pivotal role in oncology and image-guided therapy. As the founder of Cage Pharma, Inc. and its predecessor PreScience Labs, Jeff successfully raised over $6 million to advance bio-pharmaceutical development targeting tumor metabolism. Previously, Jeff served as Chairman of the Department of Radiology and Biomedical Imaging at both Yale University School of Medicine and Yale New Haven Hospital, as well as in various esteemed positions at Johns Hopkins Medicine. Jeff holds a Doctor of Medicine degree and has a solid educational background from prestigious institutions including The Johns Hopkins University School of Medicine and the University of California, San Francisco.